These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1402156)

  • 21. Plasma triglyceride and cholesterol levels in cerebrovascular disease. Sex and angiographic differences.
    Randrup A; Pakkenberg H
    J Atheroscler Res; 1967; 7(1):17-24. PubMed ID: 6030856
    [No Abstract]   [Full Text] [Related]  

  • 22. Ticlopidine and antiplatelet therapy.
    Flores-Runk P; Raasch RH
    Ann Pharmacother; 1993 Sep; 27(9):1090-8. PubMed ID: 8219445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in the treatment of cerebrovascular disease.
    Couch JR
    Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
    Bellavance A
    Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative benefits of ticlopidine and aspirin.
    Bladin CF; Norris JW
    Stroke; 1994 Nov; 25(11):2290-1. PubMed ID: 7974560
    [No Abstract]   [Full Text] [Related]  

  • 26. Ticlopidine hydrochloride: its current use in cerebrovascular disease.
    Bronstein KS; Chadwick LR
    Rehabil Nurs; 1994; 19(1):17-20. PubMed ID: 8159859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ticlopidine for the prevention of thromboembolic stroke.
    Cowan S
    Axone; 1992 Dec; 14(2):58-9. PubMed ID: 1493112
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antithrombotic therapy after cerebral ischemia].
    Schellinger PD; Orberk E; Hacke W
    Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease.
    Droste DW; Sonne M; Siemens HJ; Kaps M
    Neurol Res; 1996 Oct; 18(5):449-53. PubMed ID: 8916060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current use of antiplatelet drugs in stroke syndromes in the USA.
    Nelson E
    Ann N Y Acad Sci; 1990; 598():368-75. PubMed ID: 2248449
    [No Abstract]   [Full Text] [Related]  

  • 32. Ticlopidine and fatal aplastic anemia in an elderly woman.
    Mallet L; Mallet J
    Ann Pharmacother; 1994 Oct; 28(10):1169-71. PubMed ID: 7841572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study.
    Harbison JW
    Stroke; 1992 Dec; 23(12):1723-7. PubMed ID: 1448821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New modalities and aspects of antiplatelet therapy for stroke prevention.
    Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
    Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preventive treatment of cerebrovascular accidents of arterial origin].
    Castillo V; Bogousslavsky J; Vuadens P
    Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients.
    Oster G; Huse DM; Lacey MJ; Epstein AM
    Stroke; 1994 Jun; 25(6):1149-56. PubMed ID: 8202972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
    Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C
    Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.
    Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B
    N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].
    Kohriyama T; Tanaka E; Katayama S; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy for secondary stroke prevention.
    Forbes CD
    Scott Med J; 1999 Apr; 44(2):54-9. PubMed ID: 10370984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.